BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30548484)

  • 41. Recurrent epigenetic silencing of the PTPRD tumor suppressor in laryngeal squamous cell carcinoma.
    Szaumkessel M; Wojciechowska S; Janiszewska J; Zemke N; Byzia E; Kiwerska K; Kostrzewska-Poczekaj M; Ustaszewski A; Jarmuz-Szymczak M; Grenman R; Wierzbicka M; Bartochowska A; Szyfter K; Giefing M
    Tumour Biol; 2017 Mar; 39(3):1010428317691427. PubMed ID: 28345455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Integrated miRNA and mRNA expression analysis uncovers drug targets in laryngeal squamous cell carcinoma patients.
    Lapa RML; Barros-Filho MC; Marchi FA; Domingues MAC; de Carvalho GB; Drigo SA; Kowalski LP; Rogatto SR
    Oral Oncol; 2019 Jun; 93():76-84. PubMed ID: 31109699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutations in the D-loop region and increased copy number of mitochondrial DNA in human laryngeal squamous cell carcinoma.
    Guo W; Yang D; Xu H; Zhang Y; Huang J; Yang Z; Chen X; Huang Z
    Mol Biol Rep; 2013 Jan; 40(1):13-20. PubMed ID: 23114912
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recurrent transcriptional loss of the PCDH17 tumor suppressor in laryngeal squamous cell carcinoma is partially mediated by aberrant promoter DNA methylation.
    Byzia E; Soloch N; Bodnar M; Szaumkessel M; Kiwerska K; Kostrzewska-Poczekaj M; Jarmuz-Szymczak M; Szylberg L; Wierzbicka M; Bartochowska A; Kalinowicz E; Grenman R; Szyfter K; Marszalek A; Giefing M
    Mol Carcinog; 2018 Jul; 57(7):878-885. PubMed ID: 29566279
    [TBL] [Abstract][Full Text] [Related]  

  • 45. KAI1/CD82 and MRP1/CD9 serve as markers of infiltration, metastasis, and prognosis in laryngeal squamous cell carcinomas.
    Zhang BH; Liu W; Li L; Lu JG; Sun YN; Jin DJ; Xu XY
    Asian Pac J Cancer Prev; 2013; 14(6):3521-6. PubMed ID: 23886139
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel.
    Mann JE; Kulkarni A; Birkeland AC; Kafelghazal J; Eisenberg J; Jewell BM; Ludwig ML; Spector ME; Jiang H; Carey TE; Brenner JC
    Head Neck; 2019 Sep; 41(9):3114-3124. PubMed ID: 31090975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Zinc finger protein x-linked (ZFX) contributes to patient prognosis, cell proliferation and apoptosis in human laryngeal squamous cell carcinoma.
    Yang F; Ma H; Feng L; Lian M; Wang R; Fan E; Fang J
    Int J Clin Exp Pathol; 2015; 8(11):13886-99. PubMed ID: 26823701
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HSP47 is associated with the prognosis of laryngeal squamous cell carcinoma by inhibiting cell viability and invasion and promoting apoptosis.
    Song X; Liao Z; Zhou C; Lin R; Lu J; Cai L; Tan X; Zeng W; Lu X; Zheng W; Chen J; Su Z
    Oncol Rep; 2017 Oct; 38(4):2444-2452. PubMed ID: 28849239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Detection of mutation in exon 5 and exon 8 of PTEN in laryngeal squamous cell carcinoma].
    Bai WL; Gao H; Ren Z; Pan ZM
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 39(1):13-6. PubMed ID: 15127561
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The study on the expression of tumor-suppressor gene p15 and Rb in laryngeal squamous cell carcinomas].
    Wen S; Wang B; Chen Y; Huang-Fu H
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Sep; 17(9):543-4. PubMed ID: 14658190
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
    van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
    Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNA‑503 serves an oncogenic role in laryngeal squamous cell carcinoma via targeting programmed cell death protein 4.
    Shuang Y; Zhou X; Li C; Huang Y; Zhang L
    Mol Med Rep; 2017 Oct; 16(4):5249-5256. PubMed ID: 28849168
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [DJ-1 expression in laryngeal squamous cell carcinoma and its relationship with tumor recurrence and metastasis].
    Zhu XL; Wen WP; Lei WB; Chai LP; Hou WJ; Wen YH; Wang XR
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Jun; 45(6):497-501. PubMed ID: 21055329
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.
    Fan L; Zhang A; Deng P
    Biomed Pharmacother; 2019 Sep; 117():109174. PubMed ID: 31387183
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between laryngeal squamous cell carcinoma and polymorphisms in tumor necrosis factor related apoptosis induce ligand (TRAIL), TRAIL receptor and sTRAIL levels.
    Verim A; Turan S; Farooqi AA; Kahraman OT; Tepe-Karaca C; Yildiz Y; Naiboglu B; Ozkan NE; Ergen A; Isitmangil GA; Yaylim I
    Asian Pac J Cancer Prev; 2014; 15(24):10697-703. PubMed ID: 25605161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Survivin and laryngeal carcinoma prognosis: nuclear localization and expression of splice variants.
    Marioni G; Agostini M; Bedin C; Blandamura S; Stellini E; Favero G; Lionello M; Giacomelli L; Burti S; D'Angelo E; Nitti D; Staffieri A; De Filippis C
    Histopathology; 2012 Aug; 61(2):247-56. PubMed ID: 22416874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Downregulation of thrombospondin-1 by DNA hypermethylation is associated with tumor progression in laryngeal squamous cell carcinoma.
    Huang C; Zhou X; Li Z; Liu H; He Y; Ye G; Huang K
    Mol Med Rep; 2016 Sep; 14(3):2489-96. PubMed ID: 27485791
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Study of mRNA expression level and hypermethylation of CHFR promoter in the laryngeal squamous cell carcinoma tissue].
    He L; Ji W; Yang J; Zhao X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 24(15):673-7. PubMed ID: 20942233
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
    Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
    Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IQGAP1 silencing suppresses the malignant characteristics of laryngeal squamous cell carcinoma cells.
    Wang X; He C; Li C; Ren B; Deng Q; Gao W; Wang B
    Int J Biol Markers; 2018 Jan; 33(1):73-78. PubMed ID: 28708206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.